Drug Pipeline

Preventing disease-causing kinases from adopting aggressive shapes (conformations) and solving the problem of drug resistance provides patients with more durable kinase blocking therapies. These Deciphera candidates also exhibit high selectivity profiles, enabling the inhibition of specific disease-causing kinases without affecting the function of a host of other kinases required for normal health. This translates into safer therapies and extends the clinical use of kinase inhibitors into the area of chronic non-oncology indications.

To learn additional information, please select a drug candidate below.